MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 106 filers reported holding MARINUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $353,806 | -19.1% | 43,951 | +9.1% | 0.00% | – |
| Q2 2023 | $437,484 | +8649.7% | 40,284 | +5285.6% | 0.00% | – |
| Q1 2023 | $5,000 | +249900.0% | 748 | +20.6% | 0.00% | – |
| Q4 2022 | $2 | -100.0% | 620 | -75.8% | 0.00% | – |
| Q3 2022 | $17,000 | +70.0% | 2,560 | +23.7% | 0.00% | – |
| Q2 2022 | $10,000 | -99.6% | 2,070 | -99.3% | 0.00% | – |
| Q1 2022 | $2,738,000 | -22.7% | 292,860 | -1.8% | 0.00% | – |
| Q4 2021 | $3,542,000 | -0.2% | 298,121 | -4.4% | 0.00% | – |
| Q3 2021 | $3,550,000 | +51.1% | 311,925 | +138.1% | 0.00% | – |
| Q2 2021 | $2,349,000 | -20.2% | 130,986 | -31.1% | 0.00% | – |
| Q1 2021 | $2,943,000 | +48.7% | 190,093 | +17.2% | 0.00% | – |
| Q4 2020 | $1,979,000 | -13.7% | 162,259 | -17.8% | 0.00% | – |
| Q3 2020 | $2,294,000 | – | 197,385 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 2,145,337 | $17,269,963 | 7.70% |
| Bleichroeder LP | 1,872,463 | $15,073,327 | 3.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,204,942 | $41,899,783 | 2.26% |
| Opaleye Management Inc. | 584,000 | $4,701,200 | 1.53% |
| Bain Capital Life Sciences Investors, LLC | 1,431,058 | $11,520,017 | 1.29% |
| Cormorant Asset Management, LP | 2,625,000 | $21,131,250 | 1.23% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 290,000 | $2,337,400 | 0.79% |
| Ikarian Capital, LLC | 746,069 | $6,005,856 | 0.72% |
| Eventide Asset Management | 4,529,997 | $36,466,476 | 0.66% |
| Altium Capital Management LP | 125,033 | $1,006,516 | 0.52% |